Remove companies ginkgo-bioworks
article thumbnail

YC and Ginkgo Bioworks announce new partnership for synthetic biology startups

Y Combinator

Ginkgo Bioworks was the first bio company YC funded, back in summer 2014, which makes us especially delighted to announce a new partnership between YC and Ginkgo. Ginkgo Bioworks programs cells. Today, Ginkgo’s core business is programming cells for large companies like Bayer and Roche.

startup 86
article thumbnail

Early-stage Frontier Tech Companies boosted by Bison Ventures’ New Fund

American Entrepreneurship

The Fund’s six initial investments have CEOs from underrepresented groups of which 50% are women W ashington -based Bison Ventures announced the closing of its inaugural fund that will invest in early-stage frontier technology companies. Most venture dollars today continue to chase pure software companies.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Ginkgo Bioworks (S14) is going public today

Y Combinator

Ginkgo Bioworks is the first biotech company YC funded, and today they are going public. To celebrate their IPO, here’s the story of how Ginkgo Bioworks ended up in YC, and what their journey was like as YC’s first biotech startup. That’s what we’re building at Ginkgo.

article thumbnail

YC Firesides and a new book by Surbhi Sarna

Y Combinator

If I had to boil it down to one sentence I’d say: she turned a teenage cancer scare into a company that was eventually acquired for $275M by Boston Scientific. She joined YC as a Visiting Partner before launching her second company TigerEye. Reshma and Jason still run the company today.

culture 96
article thumbnail

Gingko Bioworks, valued at $15B, begins trading today: Here’s how their business works

TechCrunch

Gingko Bioworks, a synthetic biology company now valued at around $15 billion, begins trading on the New York Stock Exchange today. billion for the company. It’s probably intentional: Jason Kelly, the CEO of Ginkgo Bioworks, has been re-reading Jurassic Park this week, he tells TechCrunch. . million in 2019. .

article thumbnail

Forsaking funding at a $1 billion valuation, Solugen preps a new green chemical product and a big 2021

TechCrunch

Late last year, Solugen , a startup using synthetic biology to take hydrocarbons out of the chemicals industry, decided against pursuing a new round of funding that would have valued the company at over $1 billion, TechCrunch has learned. Chemicals are everywhere and they’re a huge business.

article thumbnail

2021 — YC Year in Review

Y Combinator

In 2021, many YC founders led their companies to achieve outstanding results, and we are honored to be part of these companies’ history. This year presented an exceptional challenge to startups and established companies alike as the world struggled through a full year in the grip of the COVID-19 pandemic. We reflected on the.

health 92